Teva invests in $300M Philadelphia distribution center
Generic drug giant Teva Pharmaceutical, after years of a dramatic and sometimes controversial process to select a new home for its distribution center, is breaking ground on a $300 million building off Red Lion Road in Philadelphia, according to the Philadelphia Business Journal.
The project consists of three buildings totaling 200,000 square feet. It is expected to be completed by the second half of 2013 and will employ more than 200 workers. Within three years Teva, which is based in Israel and has its U.S. headquarters in North Wales, Pa., is expected to add an additional 200 positions.